Nutrients and pharmacological management of Metabolic syndrome
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Department of pharmacology and pharmacotherapy | hu_HU |
| dc.contributor.author | Ghim, Nayoung | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Megyeri, Attila | |
| dc.contributor.opponentdept | Kenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztály | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.date.accessioned | 2022-08-29T09:18:42Z | |
| dc.date.available | 2022-08-29T09:18:42Z | |
| dc.date.created | 2021-07-06 | |
| dc.description.abstract | Metabolic syndrome is a public health problem defined by a cluster of interconnected components that increase the risk of cardiovascular atherosclerotic diseases and T2DM. Metabolic syndrome has a pleiotropic pathophysiology related to increasing body fat and distribution and insulin resistance. Recently approved anti-obesity drugs can be prescribed to reduce body weight, particularly abdominal visceral fat. Anti-diabetics such as metformin, lipid-lowering medications, RAAS blockers, and calcium channels exert many metabolic effects including anti-inflammation. Treatment is best achieved with a combination of lifestyle modifications and therapeutic agents that can help reduce insulin resistance, and others that target specific components of metabolic syndrome. | hu_HU |
| dc.description.corrector | hbk | |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 35 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/336860 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Metabolic syndrome | hu_HU |
| dc.subject | Diabetes | hu_HU |
| dc.subject | Insulin resistance | hu_HU |
| dc.subject | Obesity | hu_HU |
| dc.subject | Antidiabetics | hu_HU |
| dc.subject.dspace | Antidiabetics | hu_HU |
| dc.subject.dspace | Treatment of Dyslipidemia | hu_HU |
| dc.subject.dspace | Anti-Obesity Drugs | hu_HU |
| dc.subject.dspace | Antihypertensives | hu_HU |
| dc.subject.dspace | COVID and Metabolic Syndrome | hu_HU |
| dc.subject.dspace | Intermittent fasting | hu_HU |
| dc.subject.dspace | Very low carbohydrate ketogenic diet | hu_HU |
| dc.title | Nutrients and pharmacological management of Metabolic syndrome | hu_HU |